Moog Inc. (NYSE: MOG-A) — A Real Moat That Never Earned Its Keep, Repriced as If It Finally Will

⚡ Claude’s Take

This is the author’s own independent opinion and general information only — not investment advice. The analysis in Sections 1–15 below is written position-free and carries no buy/sell recommendation and no price target, by design; the single view expressed here is the author’s alone.

Verdict: AVOID at ~$410 — a genuinely good franchise at a demonstrably wrong price. Not a short (the demand and backlog are real, the tape is vertical, and family control makes it un-squeezable), but new money here is underwriting near-perfect execution AND a friendly momentum regime simultaneously. Fair-value zone ~$285–345 (≈ 26–30x a normalized ~$11 EPS), i.e., I would want a 15–30% lower entry — around the low-$300s — before the risk/reward turns. Conviction: medium.

Moog is a real thing: flight-critical actuation designed onto the F-35, the 787, the A350, and a widening set of missiles and spacecraft, with switching costs measured in multi-year requalification programs. That moat is durable. The problem is that in thirty-plus years it has never converted into high returns — through-cycle operating margins of ~8–11% and ROE around 8%, because Moog is an OEM-content and customer-funded-development shop selling into an oligopsony (Boeing, Lockheed, the U.S. Government), not a proprietary-aftermarket pricing engine like TransDigm or HEICO. Every one of its four segments earns a nearly identical ~11–12% operating margin; there is no crown jewel. Yet the stock has re-rated roughly six-fold since 2021 to ~46x trailing / ~39x FY26E earnings and ~24x EV/EBITDA — the richest valuation in its entire public history (98th percentile on ten years of its own multiples) — pricing a margin-and-returns transformation that the company’s own history gives no precedent for. Roughly half of the two-year move is multiple, not earnings.

The framing is momentum, not value: 12-month Sharpe of 3.7, +119% trailing return, sitting 4% below an all-time high, and — tellingly — the stock’s closest factor cousins are literally small-cap momentum ETFs. Sell-side is chasing (average target ~$485, JPMorgan just initiated Overweight at $520), which is an endorsement of the trend, not a contrarian tell. I love the business and dislike the setup: you are paying near the analytical bull case, with a base case that is roughly flat and a bear case near -40%, on an 11%-ROIC company whose incentive plan pays management to grow sales and margin but contains no return-on-capital or cash-flow metric. What would flip me bullish: two-plus years of consolidated operating margin sustained at 14%+ with ROIC durably above 13% — proof the transformation is structural, not cyclical. What would flip me more bearish (toward a short): a book-to-bill below 1.0 for two quarters or a guide-down while the multiple still prints north of 30x. Tag: a thoroughbred, bought at the top of the stretch.

📈 Stock Price Action — Five-Year Event Map

Factual price history and its most probable drivers. Price moves are FACT (AZI five-year daily series); attributed causes are INTERPRETATION. No recommendation or price target here.

Moog has traded a one-way street, not a round trip. From a COVID-era trough close of ~$65 (Dec 2021) the shares compounded almost without interruption to an all-time high of $425.85 (29 Jun 2026) and sit at $409.65 (23 Jul 2026) — roughly a 6.3x move in under five years, of which the sharpest leg (a near-doubling) came in the first seven months of 2026 alone. The 52-week range is $181.72–$425.85; the stock is -3.8% off its high, +68% year-to-date and +119% over twelve months. Beta ~1.19. This is a stock priced at the very top of its own cycle.

Cycle narrative. (1) The base was set in a commercial-aerospace downcycle: Moog’s Boeing/Airbus OEM content was still destocking while defense firmed. (2–3) The 2023–24 legs were fundamental — real revenue reacceleration and the first leg of the self-help margin program lifting operating margin from ~8.5% toward 11%. (4) The only meaningful drawdown of the era, a ~15% dip, came on the April-2025 tariff shock and an industrial-demand air-pocket — a useful reminder of how the name trades when the narrative wobbles. (5–6) The 2025–26 melt-up is where price outran the business: two consecutive quarters of headline EPS up 38–48% (flattered by a depressed prior-year base), a record backlog, and serial guidance raises turned Moog into a defense-momentum darling, with the multiple — not earnings — doing roughly half the work. (7) The most recent action is consolidation just below the high, with the sell-side racing price targets upward behind the tape rather than ahead of it.

1. Executive Summary

Moog Inc. designs and builds precision motion and fluid controls — principally flight-critical actuation — for aerospace, defense, and industrial customers. It is a $3.86B-revenue (FY2025), four-segment franchise (Space & Defense 29%, Military Aircraft 23%, Commercial Aircraft 23%, Industrial 25%), with roughly 75% of sales in aerospace & defense, 38% to the U.S. Government, and Boeing its only >10% customer.

The investment debate is unusually clean. The moat is real; the returns are not. Moog’s actuation content, once designed onto a platform, ships for that platform’s 20-to-40-year life, and requalifying an alternative on a man-rated or missile program is a multi-year undertaking primes will not attempt mid-program. That is a genuine intangibles-plus-customer-captivity moat in Greenwald’s taxonomy. But it has never produced high returns: through-cycle operating margins of ~8–11%, ROE around 8%, and ROIC around 10–11% — barely at or above the cost of capital — because Moog sells OEM content and customer-funded development into an oligopsony, with aftermarket only ~14% of revenue. Its uniform ~11–12% segment margins stand in stark contrast to the 40%+ margins TransDigm and HEICO extract from proprietary sole-source aftermarket — the model Moog explicitly is not.

Onto this average-return business the market has layered an extraordinary re-rating. At $409.65 the stock trades at ~46x trailing and ~39x forward (FY26E $10.60 guidance) earnings, ~24x TTM EV/EBITDA, and the 98th percentile of its own ten-year valuation history — its richest multiple ever. The bull case is a genuine defense super-cycle (missile replenishment, hypersonics, space) plus a credible self-help operating program (“80/20” simplification and value-based pricing) that has lifted adjusted operating margin toward 13–13.4%. Both are real. The problem is durability and price: the current valuation underwrites op margins climbing to the mid-teens and sustained high-single/double-digit growth and through-cycle ROIC clearing WACC — a transformation with no precedent in three decades of Moog history — while leaving essentially no margin of safety. Quality-of-earnings caveats reinforce the caution: the headline H1-FY26 EPS growth is flattered by a depressed prior-year base and admitted order pull-forwards; free-cash conversion is still only ~55–60%; a commercial-aftermarket revenue-recognition restatement sits in the very segment now driving growth; and the executive incentive plan rewards sales and margin but contains no return-on-capital, cash-flow, or TSR metric — the exact design that yields growth-at-WACC. Insiders are selling into strength with zero open-market purchases, and dual-class family control removes any activist catalyst.

The tape frames the situation precisely: this is a crowded momentum trade (12-month Sharpe 3.7, factor-cousins are momentum ETFs), not a distressed or contrarian one. Consensus is bullish and chasing (average target ~$485; JPMorgan Overweight $520). Our embedded-expectations work puts a base-case fair value roughly flat-to-below spot, with a bear case near -40% and a bull case (+7–17%) that the stock already sits inside. This report takes no position (see the fenced Claude’s Take above for the one subjective view); the body that follows argues the evidence, section by section.

2. Business Overview

What Moog does. Moog Inc. (NY corporation, formed 1951; headquartered in East Aurora, New York; ~13,500 employees across 20+ countries) designs, manufactures, and integrates high-performance precision motion and fluid controls — hydraulic, electrohydraulic, and electromechanical actuation, plus the electronics and software that control them. In plain terms: when an aircraft flight surface, a missile fin, a rocket nozzle, or an industrial machine must move with precision and reliability, Moog makes the actuator and control system that moves it. The company’s heritage is flight-critical actuation (the systems that, if they fail, the aircraft is lost), which is the root of both its moat and its risk profile. (FY25 10-K, Item 1.)

Segment structure (reorganized to four). Moog recently split its former “Aircraft Controls” segment into two, and now reports four operating segments. FY2025 net sales of $3,860.6M split as follows (FY25 10-K, Note 22):

The single most important structural fact in this table is that the four segment margins are nearly identical at ~11–12% — there is no high-return crown jewel anywhere in the portfolio. This is the defining contrast with peers: Curtiss-Wright has a ~27%-margin Defense Electronics franchise; TransDigm and HEICO run aftermarket-heavy models at 40%+ and 20%+ margins. Moog’s deepest-moat business (Space & Defense, with the highest switching costs) earns just ~12%. (FY25 10-K, Note 22; peer cross-read.)

Sub-market detail. Within Space & Defense, Space is ~$474.5M and Defense ~$638.5M. Within Industrial, Industrial Automation ($401.7M) has been actively shrunk (from $485.5M in FY23, −17% over two years), while Medical ($270.7M), Energy ($141.7M), and Simulation & Test ($141.6M) round out the segment. (FY25 10-K, Note 22.)

OEM vs. aftermarket — the crux of the low-return story. Moog is predominantly an original-equipment-content business, not an aftermarket-parts business. Military Aircraft is OEM $687.3M / aftermarket $200.9M (23% aftermarket); Commercial Aircraft is OEM $573.0M / aftermarket $330.9M (37% aftermarket, and up 26% YoY — the fastest-growing, highest-quality revenue line). Total aircraft aftermarket is roughly $531.8M, ~14% of company revenue. Unlike the proprietary sole-source spare parts that let TransDigm and HEICO price with impunity, much of Moog’s military aftermarket sits on government cost-plus terms (no pricing power) and its commercial MRO flows partly through OEMs and airlines. The moat protects the contract and the share, not the price. (FY25 10-K, Item 1 + Note 22.)

Revenue recognition and recurrence. 64% of revenue is recognized over time ($2,481.6M — long-cycle U.S. Government contracts and repair/overhaul) and 36% point-in-time ($1,379.0M, predominantly Industrial). There is no subscription revenue. “Recurring-like” durability comes from long platform lives (the F-35, 787, and A350 ship for decades), aftermarket spares/MRO (~14%), and over-time program backlog — real visibility, but shorter and lower-margin than Curtiss-Wright’s 36-month backlog. (FY25 10-K; Q2 FY26 10-Q.)

Customers and geography. By end customer, FY25 sales were Commercial $1,974.2M (51.1%), U.S. Government including OEM $1,461.4M (37.9%), and Other $425.0M (11.0%). Boeing at $396.8M (10%) is the only customer above 10% (down from 12% in FY24). Geographically, ~63% U.S. and ~37% international (Germany $247.4M the largest foreign market). (FY25 10-K, Note 22.)

Backlog. Twelve-month backlog was $3.0B at fiscal year-end (27 Sep 2025), +20% YoY, and grew to a record $3.31B by Q2 FY26 (28 Mar 2026). Total (multi-year) backlog was $6.01B at FY25 year-end (+19%). (FY25 10-K, Item 1; Q2 FY26 10-Q.)

Verdict. A high-quality, mission-critical, well-diversified motion-control franchise with genuine multi-year visibility — but structurally an OEM-content and development business whose economics (uniform ~11–12% segment margins, only 14% aftermarket) are average, not exceptional. The business is good; the unit economics are the ceiling on the thesis.

3. Industry Dynamics

Market structure — a consolidating oligopoly. Flight-critical actuation is a tight oligopoly of tier-1/tier-2 specialists — Moog, Safran, Parker Aerospace, Eaton, Liebherr (Europe), Woodward, and the vertically integrated primes — protected by exceptionally high barriers: flight-critical/man-rated qualification, multi-year certification, decades-long platform design-win lock-in, and ITAR/classified constraints on the defense side. New entry into primary flight control is effectively impossible. Critically, the supplier base is consolidating, not expanding: in July 2025 Safran acquired Collins Aerospace’s (RTX) flight-control and actuation business for $1.8B, taking Safran to roughly 25% of the ~$11.2B global flight-control market, while — as a DOJ remedy — Collins’ North American electromechanical actuation (EMA) unit was divested to Woodward, materially bulking a direct competitor. (Reuters/Safran/Janes, Jul 2025.)

Demand — a genuine defense super-cycle plus a commercial recovery. The 75% of Moog that is aerospace & defense sits in front of three real tailwinds: (1) a defense super-cycle — missile and munitions restocking (PAC-3 MSE, tactical and hypersonic programs), elevated global defense budgets, and rising space-launch cadence, with management citing production-rate increases of “2 to 4x” on key missile-defense programs over the next few years; (2) a commercial-aero recovery — Boeing 737 MAX / 787 and Airbus A350 / A320 build-rate ramps plus a growing, aging installed base lifting aftermarket (+26% in FY25, the cleanest structural tailwind); and (3) space as an emerging warfighting domain. U.S. Government at 38% of sales provides budget-protected demand. (FY25 10-K MD&A; Q2 FY26 transcript.)

The Industrial tail is being pruned. The 25% Industrial segment is a structurally mediocre, cyclical, fragmented market; management is rationally shrinking it (Industrial Automation −17% over two years, R&D cut from $51.3M to $35.8M, restructuring concentrated here). In Marathon capital-cycle terms this is disciplined supply withdrawal from a low-return arena — a positive. (FY25 10-K, Note 22.)

Marathon capital-cycle read. The A&D core is a favorable setup: actuation supply is consolidating (Safran/Collins/Woodward) while demand surges (defense restock + commercial build-rate + space). That is a classic capital-cycle configuration that supports pricing and returns for disciplined incumbents. But the surplus from tightening supply accrues disproportionately to the buyer side — Boeing, Airbus, Lockheed, and the U.S. Government are an oligopsony that captures much of the value via cost-plus, fixed-price-incentive, and negotiated OEM pricing. This is the same dynamic seen in naval nuclear (Curtiss-Wright, BWXT): a deep moat in a high-barrier industry, but a moderate profit pool because the customer holds the whip hand.

Verdict. Structurally good and improving for the 75% A&D core — high barriers, consolidating supply, budget-protected and build-rate-driven demand, long-cycle visibility. But it is a high-barrier / moderate-profit-pool industry: oligopsony buyer power caps how much of the surplus a component supplier can retain. The Industrial 25% is a poor industry being correctly exited. Net: an attractive, improving franchise industry — not a fat-margin one. That distinction is the entire valuation debate.

4. Competitive Position

Name the moat. In Greenwald’s taxonomy, Moog’s advantage is intangibles plus customer captivity, with niche scale in specific actuation categories — not corporate economies of scale (it is sub-scale versus a ~25%-share Safran) and not network effects. The mechanism has three legs: (1) design-win lock-in — once Moog’s actuation is designed onto the F-35, 787, A350, or a missile, it ships for the 20–40-year platform life; (2) qualification/certification switching costs — requalifying an alternative on a man-rated or missile program is a multi-year, high-risk undertaking that primes and the government will not attempt mid-program; and (3) proprietary engineering know-how in high-performance electrohydraulic and electromechanical actuation. The captivity is genuine and durable, and it passes Greenwald’s share-stability test: Moog holds its niche flight-critical positions for platform lifetimes with low churn. (FY25 10-K, Item 1; frameworks skill.)

The central tension — a real moat that fails the returns test. Despite that moat, Moog’s returns are only about the cost of capital: FY25 ROE 8.4%, ROIC ~10.8%, ROA 5.5%, gross margin ~27%. This is not a one-off — it is decades-persistent. Moog has never earned high returns. A genuine moat that does not show up in returns demands an explanation, and there are four, all evidence-based:

1. The wrong business model versus TransDigm/HEICO. Moog is an OEM-content and customer-funded-development shop. Its aircraft aftermarket is only ~14% of revenue and is largely not proprietary sole-source pricing power — military aftermarket is often on government cost-plus terms, and commercial MRO flows partly through OEMs and airlines. TransDigm earns ~50% EBITDA margins because ~90% of its value is proprietary sole-source aftermarket with annual price escalation; HEICO earns 20%+ ROE on PMA parts and repair. Moog’s moat protects the contract and share, not the price.
2. Oligopsony buyer power. With Boeing at 10% and the U.S. Government at 38%, primes and government capture surplus through cost-plus, fixed-price-incentive, and negotiated pricing; 64% of revenue is over-time (largely government/long-cycle) where margins are structurally capped.
3. Capital and working-capital intensity. Long-cycle over-time contracts tie up large contract assets and inventory; PP&E is ~$1.02B, capex ~3.7% of sales, and total assets of $4.43B on $3.86B of sales give asset turns of only ~0.87x. The heavy denominator crushes ROIC.
4. Culture and capital-allocation history. Dual-class family/trust control and an engineering-led, employee-first culture historically under-optimized margins and shareholder returns for decades; operating margin only recently pushed from 8.4% (FY21) to ~11% (FY24–25) under CEO Pat Roche’s self-help program.

Peer comparison. Against Curtiss-Wright (ROE ~12%, ROIC ~14%, with a 27%-margin Defense Electronics crown jewel), Moog’s naval-like deep moat lacks CW’s high-margin offset. Against TransDigm (~50% EBITDA margin) and HEICO (20%+ ROE), the aftermarket-pricing gap is the whole story. Woodward (mid-teens ROE), newly bulked in EMA via the Collins divestiture, is a directly strengthened competitor. Parker, Honeywell, Eaton, Safran-Collins, and Liebherr are larger, more diversified, deeper-pocketed flight-control rivals. Moog is a focused but sub-scale independent. (Peer cross-read; ROIC.ai; Safran/Collins/Woodward news.)

Verdict. A durable-but-capital-heavy niche franchise that has never converted its moat into high returns. The intangibles/switching-cost moat is real (it protects share, backlog, and decades of content), but it structurally caps at ~WACC returns because Moog sells OEM content and systems into an oligopsony under a development-heavy, working-capital-intensive, cost-plus-inflected model — the antithesis of the proprietary-aftermarket engine. Moog is a good, defensible, above-average supplier. It is not a wide-moat, high-return compounder. The current re-rating prices exactly the returns transformation that thirty-plus years of Moog history did not deliver.

5. Growth History and Forward Opportunities

Historical growth — a GDP-plus organic industrial. Consolidated net sales grew FY23 $3,316M → FY24 $3,609M (+9%) → FY25 $3,861M (+7%), a mid-single-digit multi-year CAGR; diluted GAAP EPS grew $5.47 → $6.45 (+18%) → $7.33 (+14%). By segment (FY23→FY25): Space & Defense $947M → $1,113M; Military Aircraft $720M → $888M (with operating margin climbing 8.4%→11.1%); Commercial Aircraft $666M → $904M (the fastest grower, on OE ramp + aftermarket +26%); and Industrial $983M → $956M (the only shrinking segment, by design). Growth is overwhelmingly organic — acquisitions in the period are small bolt-ons (DCL, ~$6M FY24; COTSWORKS fiber optics, Jul 2025) offset by Industrial divestitures. Moog is deliberately pruning, not rolling up. (FY25 10-K, Note 22 & cash flows.)

The FY26 acceleration — the re-rating catalyst. FQ1 FY26 (Jan 2026) posted revenue +21% with record sales in all four segments and adjusted EPS $2.63 vs $1.78; FQ2 FY26 (Apr 2026) posted revenue +13% and adjusted EPS $2.64 vs $1.92, with Space & Defense +16%, Commercial Aircraft +15%, Military Aircraft +10%, and Industrial +9%. Twelve-month backlog rose ~33% YoY. Management raised FY26 EPS guidance from ~$10.00 (Nov 2025) to $10.20 (FQ1) to $10.60 ±$0.20 (FQ2). (Transcripts FQ1/FQ2 FY26.)

The durable, high-quality drivers are real: a missile-replenishment super-cycle (missiles >$200M in FY25 growing ~20%/yr, expected >$250M in FY26; PAC-3 ramp cited from 650 to 2,000 missiles/yr, with Moog winning >$100M of PAC-3 orders including a partial competitor takeaway); embedded flight-critical actuation with 100% on-time/quality delivery that wins share when primes are capacity-constrained; a commercial OE ramp plus aftermarket on a growing fleet (>$1B commercial bookings in FQ1); and space thrust-vector content (“a piece of Moog hardware flies into space every week,” plus Artemis II content and a >$100M Meteor satellite follow-on). These are multi-year, contracted, high-switching-cost revenues. (FQ1/FQ2 FY26 transcripts.)

But the reported rate is over-extrapolated — the key skeptical point. The headline +37–48% H1-FY26 EPS growth is flattered by an easy comp: H1 FY25 was the tariff/supply-chain trough (FQ2 FY25 EPS of $1.92 was actually down from $2.19 a year earlier). Revenue growth (+21%/+13%) is the cleaner, still-strong signal. Management’s own FQ3 FY26 guide of ~$2.65 is only ~+12% YoY — deceleration is already baked into guidance as comps normalize. And management explicitly conceded pull-forwards: the V-22 spares order was “basically a year’s worth of orders” pulled into FQ1, and MV-75 (FLRAA) development “peaked earlier than planned.” The lower-quality growth pockets — data-center liquid cooling (~$50M FY26, a commoditizable pump with undisclosed margins and AI-capex cyclicality) and readiness-driven order timing — should not be capitalized at a premium multiple. (FQ1/FQ2 FY26 transcripts.)

Forward opportunities. $6.01B total / $3.0B+ twelve-month backlog gives multi-year visibility; missile-scope expansion and competitor displacement via the operational-excellence flywheel; counter-UAS (the Echodyne RIwP demo, May 2026 — detect/track/engage Group 1–3 drones in <3 seconds); a Niron Magnetics partnership for rare-earth-free actuators in guided munitions (China supply-chain de-risking); space as a warfighting domain; and bolt-on M&A optionality (a new Chief Strategy & Corporate Development role plus leverage headroom at 1.8x versus a 2–3x target). Management pointedly declined to quantify price versus volume (“we haven’t given out the pricing benefit… volume and demand is the biggest part”), so the durability of the value-based-pricing margin lift is externally unverified. (FQ1/FQ2 FY26 transcripts; BusinessWire.)

Verdict. High-quality growth in the core, over-extrapolated pace. The durable base is contracted, embedded, structural defense/aero super-cycle demand — genuinely attractive at high-single-digit organic. But the market is capitalizing a peak growth rate (H1-FY26 +37–48% EPS) that is partly an easy-comp and pull-forward artifact and that management’s own guidance already shows decelerating. The acceleration premium — not the base growth — is the risk.

6. Financial Quality

Reconciliation and the real margin story. The income statement ties cleanly to the FY25 10-K: net sales $3,860.6M, COGS $2,803.3M, gross margin 27.4% (FY24 28.1%, FY23 27.1% — gross margin is flat-to-down, so the “margin expansion” story is an operating-expense/mix story, not a gross-margin story). SG&A is 14.3% of sales; company-funded R&D $93.7M (2.4%, down from $112.8M — a ~$19M / ~50bps tailwind to operating income that is a mix shift toward customer-funded development, not durable leverage, and raises an under-investment question versus peers at 3–5%). (FY25 10-K.)

Quality of earnings — GAAP EPS is depressed, not flattered. A common misread is that a large “non-operating income” line flatters earnings. The opposite is true. The ~$97M non-operating bucket (FY25) is a net expense that decomposes to interest $72.1M + asset impairment $5.4M + restructuring $10.0M + other $9.6M. There is no non-service pension credit or one-time gain propping up FY25/FY24 operating income (the only pension settlement, in FY23, was a $12.5M non-cash charge largely offset by a building-sale gain). So reported EPS is if anything conservative. Two genuine distortions to note: (i) the FY24→FY25 comparison is flattered by roughly $30M of lower restructuring/impairment charge load (Industrial simplification winding down) rather than pure operating leverage — normalize by a mid-cycle ~$15–20M/yr charge run-rate; and (ii) FY24’s 22.6% tax rate was flattered by a UK capital-investment incentive, normalizing to 24.8% in FY25 — so FY25’s +14% EPS was achieved despite a higher tax rate, a positive signal. SBC is low and high-quality at $16.7M (~0.4% of sales), so GAAP and adjusted EPS are close. (FY25 10-K MD&A.)

The ROIC bridge — the core quality tension. NOPAT ≈ $409.7M operating income × (1 − 0.248) ≈ $308M; invested capital ≈ equity $1,992.6M + net debt $883.7M ≈ $2,876M → ROIC ≈ 10.7% (matching ROIC.ai’s 10.76%). ROE is just 8.4%, ROA 5.5%. ROIC improved from 8.2% (FY21) to 11.7% (FY24) but slipped to 10.8% (FY25) — it is plateauing at barely above an estimated ~9–10% WACC. This is a cyclical margin recovery layered on Industrial pruning, not proof of structural scale economics. (ROIC.ai; FY25 10-K.)

Free cash flow — a real but modest and seasonal turnaround. FCF (operating cash flow − capex) has been poor and volatile: FY20 $190.9M, FY21 $164.5M, FY22 $107.4M, FY23 −$37.7M, FY24 $45.9M, FY25 $128.4M (only 55% of net income). TTM through Q2 FY26 is ~$310M — a genuine improvement, but (a) heavily Q4-loaded (Q4 FY25 operating cash flow of $240.6M included a +$127.7M seasonal working-capital inflow, while Q1 is always a large drain — Q1 FY26 operating cash flow was −$44.8M) and (b) still only ~1.0x net income. Note: do not use the $643M “FCF-to-firm” figure that appears in aggregator EV models — it overstates true free cash flow by roughly 2x. Management guides FY26 conversion to only ~60% — mediocre for a business at this multiple. (FY25 10-K & Q2 FY26 10-Q cash flows.)

Working-capital and capex intensity — the structural drag. FY25 inventory of $914.3M is 23.7% of sales; total receivables (billed + unbilled) of $1,251M are 32.4% of sales; the cash-conversion cycle is ~118 days. Every dollar of long-cycle revenue growth ties up ~$0.30+ in working capital — growth self-funds poorly. Capex runs 3.7–5.3% of sales (~1.4x depreciation) for the defense-ramp capacity build. This intensity is why the ROIC denominator is so heavy and returns are structurally capped. (FY25 10-K.)

Balance sheet — conservative. Total debt $945.7M, net debt $883.7M, net debt/EBITDA 1.72x (down from 2.75x in FY21), EBITDA/interest 7.1x. Tangible book is thin (~$34/share; goodwill $842M + intangibles $66M). Pension is underfunded a modest ~$157M (and declining). Liquidity is ample: a $1.1B U.S. revolver plus the March-2026 $500M 5.5% notes issuance terming out floating debt. (FY25 10-K; Q2 FY26 10-Q.)

Verdict. Economics have improved modestly with the up-cycle and Industrial pruning, but do not durably improve with scale: ROIC is plateauing at ~WACC, gross margin is flat, FCF conversion is only ~55–60% and seasonally front-loaded, and the working-capital intensity that caps returns is structural. Earnings quality is otherwise clean (low SBC, no non-op income flatter, reasonable tax), but the improvement is more cyclical than structural — which is precisely the wrong footing for a 98th-percentile valuation.

7. Capital Allocation

M&A — disciplined but minor. No transformative deals in five years: acquisitions of $77.6M (FY21), $11.8M (FY22), and $41.2M (FY25) against divestiture proceeds of $57.3M (FY22) and $13.5M (FY25) as Industrial was pruned. Moog deliberately de-emphasized M&A this cycle in favor of deleveraging and organic capacity. This is disciplined (no empire-building), but it also means the growth and margin story is organic and cyclical, not acquisition-engineered. (FY25 10-K cash flows.)

Buybacks and dividend — modest. FY25 repurchases were 511,974 shares for $100.7M (~$197 average, well below today’s ~$410 — good timing in hindsight); FY24 was zero; FY23 was $7.7M. Diluted share count fell from 33.4M (FY20) to ~32.1M (FY25), a ~4% reduction partly offset by SBC issuance. The dividend was $1.15/share in FY25 (a ~15.5% payout, lowest-quartile) and was raised again in January 2026. Neither buyback nor dividend is the return driver. (FY25 10-K.)

Balance-sheet management — competent. The March-2026 refinancing ($500M of 5.50% notes due 2034; amended $1.1B revolver + $250M term loan extended ~5 years) sensibly termed floating revolver debt into fixed, long-dated paper at tight pricing, pushing out the maturity wall. Leverage sits at the low end of the 2–3x target. This is the clearest evidence of competent stewardship. (Q2 FY26 10-Q.)

Governance — the critical flaw. The executive incentive plan (FY25 proxy CD&A) is driven by consolidated sales and adjusted operating margin — long-term PSUs vest on three-year average sales and average adjusted operating margin. There is no ROIC, no free-cash-flow, and no relative-TSR metric anywhere in the plan. Management is paid to grow revenue and expand margin, not to earn returns on capital — precisely the incentive design that produces a company which compounds sales and margin while ROIC languishes at WACC. Combined with dual-class control (28.85M Class A + 4.62M Class B; the family/trust-controlled Class B elects the majority of the board), this is an entrenched structure with no external accountability mechanism and no activist catalyst. (FY25 DEF 14A.)

Insider behavior — neutral-to-negative. A sweep of ~12 recent Form 4s (Apr-2024 → Jul-2026, including CEO Roche and several directors) found only routine option exercises (M), tax-withholding (F), gifts (G), and open-market sales (S) — with directors Coletti and Scannell selling into the June-2026 strength. Zero open-market purchases (code P). No insider is putting new money to work at these prices. (Form 4 corpus.)

Verdict. Capital allocation is conservative and shareholder-neutral — deleverage, capacity, small buyback and dividend — and competently executed on the balance sheet. But management has not demonstrably created excess value per unit of capital (ROIC ≈ WACC), the incentive plan ignores returns on capital entirely, buybacks are modest, and the recent ROIC/FCF improvement is more cyclical than structural. This is adequate stewardship of an average-return business — not the capital discipline that would justify a compounder multiple.

8. Changes and Headwinds — Last Two Years

The operating program (the real bull core). Moog is running an “80/20” simplification and continuous-improvement system paired with value-based pricing — the classic Danaher/Fortive/Altra playbook — anchored at a 2023 Investor Day with three-year (through-FY26) margin and growth goals. The evidence it is working is real and broad-based: consolidated adjusted operating margin of 13.0% (FY25) guided to 13.4% (FY26) despite 110bps of tariff drag (≈150bps of underlying expansion), with segment margins rising even on shrinking Industrial sales (Military Aircraft 8.4%→11.1%, Industrial 10.3%→11.3%). Management will host a new Investor Day later in 2026 to set post-FY26 targets. Caveats: management refuses to disclose the price component of the margin lift, and the GAAP operating margin (10.6%) sits well below adjusted (13.0%) because “one-time” simplification, restructuring, and impairment charges recur every quarter — the wedge is serial. (FQ1/FQ2 FY26 transcripts; FY25 10-K.)

Portfolio and structural changes. Continuous pruning (Industrial divestitures at the start of FY25; exit of general-aviation avionics in FQ2 FY26 via IP license; redeployment of freed Salt Lake City floor space to PAC-3 missile production) plus small bolt-ons (COTSWORKS, DCL). A commercial-aircraft supply-chain restructuring (shifting suppliers from fixed POs to rolling forecasts, a fourth-party logistics coordinator, “focused factories,” a new Philippine facility) targets a structural working-capital reduction. (FQ1/FQ2 FY26 transcripts.)

Leadership and board. CEO Pat Roche (who ran the 2023 Investor Day) and CFO Jennifer Walter lead the self-help program; a new Chief Strategy & Corporate Development Officer role (FQ1 FY26) signals M&A intent; and Carl R. Christenson — former Chairman/CEO of Altra Industrial Motion, a pedigreed 80/20 operator — was elected a Class A director effective 1 Jul 2026 (board expanded 9→10). Christenson’s background reinforces the operational-excellence direction and M&A optionality. (BusinessWire, Jul 2026.)

Headwinds. (1) Tariffs — a growing, recurring drag guided at 110bps of operating margin (raised from 80bps), driven by tariff-sensitive Industrial mix and duty-drawback complications on commercial aftermarket; partially mitigable (bonded areas, rerouting) but not eliminable, in a “fluid” regime. (2) Middle East war — wound-down forward-stocking locations, reduced flights, and fuel-driven route cuts pressuring aftermarket, partly offset by content on fuel-efficient 787/A350. (3) A commercial-aftermarket revenue-recognition restatement in the FY25 10-K (Notes 1 & 25) — correcting the accounting for a group of distinct long-term aftermarket service contracts, plus other previously-immaterial out-of-period items, revising FY23/FY24 and quarterly periods. Immaterial in size per management, but a yellow flag on earnings quality in the exact segment now driving growth. (4) FCF conversion still only ~60% and partly timing-driven. (FY25 10-K; FQ1/FQ2 FY26 transcripts.)

Verdict. On balance the changes strengthen the operating thesis — a credible, broad-based margin/operational program, disciplined pruning, low leverage post-refinancing, a pedigreed board add, and a real (if early) FCF turnaround, all riding a genuine up-cycle. But the offsets weaken earnings quality: a growing tariff drag, an aftermarket rev-rec restatement, serial “one-time” charges inflating the GAAP-to-adjusted wedge, undisclosed pricing durability, and still-mediocre cash conversion. These quality caveats are exactly why the ~39x forward multiple is the debate.

9. Risk Analysis

Overall risk read: The dominant risk is not operational — it is valuation and positioning. A high-quality but average-return business is priced for a transformation, in a crowded momentum trade, with a −64% lifetime drawdown on record. Fundamental risks (tariffs, pull-forwards, rev-rec) are individually manageable but collectively erode the earnings-quality that a 39x multiple demands.

10. Valuation Discussion

Where the stock trades. At $409.65 (23 Jul 2026), with ~32M diluted shares, market capitalization is ~$13.0B; net debt of ~$0.93B gives an enterprise value of ~$13.9B. Against TTM figures (through Q2 FY26: revenue $4.168B, EBITDA $575.5M, operating income $465.6M), that is ~24x EV/EBITDA, ~3.3x EV/Sales, ~30x EV/EBIT, ~46x trailing P/E (TTM EPS $8.88), and ~39x forward P/E (FY26E guide $10.60), on ~11% ROIC and ~8% ROE.

Own-history context — the single most important valuation fact. Current EV/EBITDA of ~24x compares to FY25 14.5x, FY24 14.7x, FY23 10.8x, and a five-year average of ~11–13x. AZI’s valuation-index composite sits at the 97.9th percentile of Moog’s own ten-year history (P/E 94th, P/B 99.6th, P/S 99.6th) — the richest the stock has ever been. The multiple has roughly doubled in under two years, so most of the price move is re-rating, not earnings growth. (AZI valuation_index; ROIC.ai.)

Peer comps — a defense-quality multiple on trough-quality economics. (Current market caps; ROIC.ai fundamentals; illustrative.)

The tension is stark: MOG-A’s ~24x EV/EBITDA is mid-pack (equal to ITT/PH, below CW/WWD/HEI) — but Moog carries the lowest operating margin and near-lowest ROIC in the cohort. Its peers earn their premiums on 15–47% margins and 13–17% ROIC; Moog is awarded a defense-quality multiple on ~11% margins and ~11% ROIC. On EV/Sales (~3.3x) it screens “cheap,” but that is the correct read for a low-margin business, not a bargain.

Embedded expectations (reverse-DCF). A single-stage Gordon model on TTM free cash flow of ~$310–360M against an EV of ~$13.9B at a ~9% WACC solves to ~4.5–4.7% perpetual growth — but that is only sensible if free cash flow first steps materially higher. Framed as an earnings path: to earn ~10%/yr from $410 over five years while the multiple normalizes from ~39x FY26E toward a still-premium ~22–25x, EPS must compound ~18–22%/yr. That in turn requires all of: (a) revenue CAGR of ~8–10% (the defense super-cycle sustained for years); (b) operating margin climbing from ~11% to ~15–16% (the self-help program delivered in full, with no give-back); and © continued buyback/deleverage. It is near-flawless execution on both the cycle and the internal program simultaneously, with no cyclical give-back and no Industrial drag priced in — and, recall, Moog has no historical precedent for sustaining even a 12% operating margin.

Scenarios (illustrative, ~FY28-anchored; EPS and multiple assumptions):

What the market prices correctly — a real record backlog, genuine multi-year defense demand, and a real, guided FY26 EPS inflection to $10.60. What it prices too aggressively — the durability of the margin gains (Moog’s structural history is ~8–11% op margin, ~8% ROE; part of the current expansion is cyclical mix and undisclosed pricing that may fade), through-cycle ROIC holding above WACC, and a momentum-driven multiple that has done roughly half the work. At spot, the price already embeds close to the bull path; the base case is roughly flat and the bear case is ~-40% — a thin margin of safety and unfavorable asymmetry. (No price target and no recommendation is expressed in this section; the scenario zones are analytical, not a call.)

11. Variant Perception

Consensus holds that Moog is an under-earning A&D franchise finally inflecting — a record backlog plus the defense super-cycle plus a self-help margin program will drive years of double-digit EPS growth, and the historic discount to CW/HEICO/TDG should close. Crucially, consensus is not merely bullish, it is chasing: the average target is ~$485, JPMorgan initiated Overweight at $520 (20 Jul 2026), and TD Cowen raised to $450 — with the stock trading below the average target, meaning the sell-side is racing price targets up behind a vertical tape. That is an endorsement of momentum, not a contrarian tell.

The strongest bull case: flight-critical actuation plus missile/space content confers real switching costs and multi-decade programs; the $3.31B backlog gives visibility; margins have genuine runway (11%→mid-teens) via mix, pricing, and portfolio simplification; the FY26 EPS inflection (+45% to $10.60) is already happening, not a forecast; and if margins reach mid-teens and growth persists, $15–16 of EPS supports $440–480 — matching the JPM/TD targets.

The strongest bear case: you are paying ~46x trailing and ~24x EV/EBITDA for a business whose through-cycle identity is ~8–11% operating margin and ~8% ROE — a value-neutral, WACC-return company. The margin expansion is partly cyclical; the Industrial 25% is structurally low-return; ~half the two-year move is multiple, not earnings; and a defense-momentum name at the 98th valuation percentile, with a −64% lifetime drawdown on record, re-rates violently if the factor rolls over (budget/CR risk, momentum rotation, or a single guide-down).

The factor read frames it precisely. FactorsToday (All-Factors model, R²~0.54) shows loadings of Market +0.99, SmallSize +0.63, DividendYield +0.47, Aerospace & Defense +0.45, Industrials +0.42, Momentum +0.31; idiosyncratic vol ~23%. The leaderboard is extreme — y1 Sharpe 3.67, m3 Sharpe 6.64, +119% trailing 12 months, −3.8% off the high — yet lifetime Sharpe is only 0.32 with a −63.7% max drawdown. And the stock’s factor-similar names are literally small-cap momentum ETFs (XSMO, PXSG, PRN) plus AAR/AIRR. The tape defines Moog as a small/mid-cap, dividend-y, defense-momentum name — a crowded momentum trade priced for continuation.

The 3–5 assumptions that matter most (with falsification tests):

1. Margin durability to mid-teens. Bull falsified by two-plus quarters of flat/declining segment op margin or management walking back LRP targets; bear falsified by a sustained 14%+ consolidated op margin through a mixed-demand quarter.
2. Defense super-cycle sustained (backlog→revenue). Bull falsified by book-to-bill below 1.0 for two quarters; bear falsified by continued >1.0 book-to-bill and DoD missile/hypersonic funding growth in appropriations.
3. ROIC clears WACC through-cycle. Bull falsified by ROIC slipping toward ~9–10% as capex/WC build for the ramp; bear falsified by ROIC durably >13–14% (which would justify a compounder multiple).
4. Multiple/regime holds. Bull falsified by a momentum/small-mid rotation or defense de-rating compressing the multiple regardless of fundamentals; bear falsified by the multiple holding >30x as growth compounds.
5. Industrial drag doesn’t offset A&D. Bull falsified by Industrial weakness capping consolidated margin; bear falsified by Industrial stabilizing or being divested.

Where consensus may be offsides: the fragile part of this stock is the re-rating, not the earnings. A 46x/24x multiple on ~11% ROIC underwrites flawless execution and a friendly momentum regime at the same time. The variant view is that even if the operating story largely delivers, the multiple leaves no room for the cyclical give-back and normalization that Moog’s own history says is likely.

12. Fact vs. Interpretation

13. Open Questions

1. Is the FY24→present margin lift a durable step-change or a cyclical peak? There is no historical precedent for Moog sustaining >11% operating margin. This is the single most important unknown for the thesis.
2. How much of the margin gain is price versus volume/mix? Management explicitly declines to quantify the pricing benefit (“it’s not half… volume and demand is the biggest part”), leaving the durability of value-based pricing externally unverified.
3. How much of H1-FY26 defense strength was genuine incremental demand versus pull-forward? Management conceded the V-22 spares order and MV-75 timing were pulled forward — the run-rate is uncertain.
4. Does the Safran/Collins consolidation help Moog (rational competitor, fewer independents) or hurt it (a ~$11B integrated Safran that can bundle/underprice on new-platform competitions)? Watch new-program win rates.
5. Is company-funded R&D at 2.4% of sales (vs. peers 3–5%) a shift to customer-funded programs or genuine under-investment that risks ceding future design wins?
6. Does the commercial-aftermarket rev-rec restatement recur or widen? It sits in the highest-growth, highest-margin revenue line.
7. Will FY26 full-year FCF hold the ~60% conversion guide through the seasonally weak first half of FY27, or was the H1 improvement largely timing (pushing out material receipts)?

14. What Must Be True

Bull case — what must be true. The defense super-cycle sustains high-single/double-digit revenue growth for years (missile replenishment, hypersonics, space, and commercial build-rate recovery all delivering), and the 80/20 + value-based-pricing program lifts consolidated operating margin durably into the mid-teens and holds it through a mixed-demand quarter, and through-cycle ROIC steps up above 13–14%, and the momentum/defense factor regime remains friendly enough to sustain a >30x multiple. In that world, ~$15–16 of FY28 EPS supports the $440–480 zone and the stock grinds higher.

Falsification test (bull): two or more consecutive quarters of flat-or-declining segment operating margin, a book-to-bill below 1.0 for two quarters, or management walking back its long-range margin targets at the upcoming Investor Day. Any one breaks the transformation thesis.

Bear case — what must be true. The margin expansion proves cyclical — a function of favorable defense mix, a temporarily lower restructuring-charge load, and undisclosed pricing that fades — so operating margin drifts back toward the low double digits; the H1-FY26 growth rate normalizes (as management’s own FQ3 guide already implies) as easy comps and pull-forwards roll off; ROIC stays pinned near WACC as the ramp consumes capex and working capital; and the 98th-percentile, momentum-driven multiple compresses toward the stock’s own historical ~12–15x EV/EBITDA. In that world the stock re-rates toward the $210–240 zone regardless of decent operating results — because the multiple, not the earnings, is the fragile part.

Falsification test (bear): a sustained 14%+ consolidated operating margin and ROIC durably above 13% across several quarters spanning a mixed-demand period — proof the transformation is structural, not cyclical — would invalidate the reversion thesis and justify a compounder multiple.

15. Source Appendix

(Full source detail is provided in the separate Source Appendix, Appendix B of the combined report. Principal sources below.)

• Moog Inc. FY2025 Form 10-K (period ended 27 Sep 2025; filed 26 Nov 2025) — Item 1 Business, Item 7 MD&A, Note 1 & Note 25 (restatement), Note 22 Segments, financial statements.
• Moog Inc. Q2 FY2026 Form 10-Q (period ended 28 Mar 2026; filed 24 Apr 2026) — segments, backlog, cash flows, senior-notes/revolver disclosure.
• Moog Inc. FY2025 DEF 14A proxy (filed 19 Dec 2025) — CD&A incentive metrics; Class A/B ownership.
• Moog earnings-call transcripts, FQ1 FY26 (30 Jan 2026) and FQ2 FY26 (24 Apr 2026) — via ROIC.ai.
• ROIC.ai — income statement, balance sheet, cash flow, profitability ratios, enterprise value, valuation multiples (MOG-A and peers).
• AZI — five-year daily price series and valuation-index own-history percentiles.
• FactorsToday — stock loadings, leaderboard, stock-info, related-stocks (factor positioning).
• BusinessWire / Reuters / Janes / Zacks / Seeking Alpha — Safran/Collins/Woodward consolidation (Jul 2025); senior-notes offering (Mar 2026); Christenson board election (Jul 2026); Echodyne/Niron partnerships; quarterly results and guidance raises; JPMorgan/TD Cowen actions.
• SEC Form 4 corpus (2024–2026) — insider-transaction characterization.

This article is independent analysis and general information only, not investment advice. The body contains no buy/sell recommendation and no price target; the single subjective view is the author’s own opinion, set out at the top. The author holds no position disclosed here.

APPENDIX A — Standard Diligence Questionnaire — Moog Inc. (NYSE: MOG-A)

Supplemental diligence questionnaire. Fact / Interpretation / Assumption labels applied where material. Report date: 2026-07-24.

General

What thoughtful questions have other investors asked about this company? The central, recurring question is the one this report is built around: why has a business with a genuine flight-critical moat never earned high returns, and is that finally changing? Related investor questions: (1) Is the margin-expansion program (80/20 + value-based pricing) a durable step-change or a cyclical peak — and how much is price vs. volume? (2) Is the defense super-cycle sustainable, and how much of recent order strength is pull-forward? (3) Can Moog structurally fix its poor free-cash conversion and working-capital intensity? (4) Does the dual-class family control cap the equity’s ceiling by insulating management from accountability? (5) Post-Safran/Collins, is Moog now dangerously sub-scale in flight controls?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? (Interpretation) Toward a cyclical high. FY26 EPS is guided to ~$10.60, up ~45% YoY, on a defense super-cycle plus a self-help margin program; H1-FY26 growth (+37–48% EPS) is additionally flattered by a depressed prior-year (tariff-trough) base and admitted order pull-forwards. Through-cycle margins are ~8–11%; current adjusted op margin ~13–13.4% is at the top of the company’s historical range.

Driven by the external environment or internal actions? (Interpretation) Both, roughly equally — the external defense/commercial up-cycle drives volume; the internal 80/20/pricing program drives margin. Neither alone would produce the current earnings level.

How stable are revenues? (Fact/Interpretation) Above-average stability for a component supplier: 64% of revenue is recognized over time on long-cycle programs; platform lives are 20–40 years; twelve-month backlog is $3.0–3.3B and total backlog ~$6.0B. But the Industrial 25% is genuinely cyclical, and defense is subject to appropriations/CR risk.

Outlook for products/services; how big is this market — growing, shrinking, domestic or international? The ~$11.2B global flight-control market is consolidating and growing (defense restock + commercial build-rate recovery + space). Moog is ~63% U.S. / ~37% international. The A&D core is growing; the Industrial tail is being deliberately shrunk.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? (Interpretation) Less competitive at the structural level — the July-2025 Safran/Collins deal consolidated the supplier base (Safran to ~25% share; Woodward gained Collins EMA). Fewer, larger, more rational competitors — but Safran’s scale is also a new bundling/pricing threat on future platform competitions.

How profitable is the business (ROIC, ROE)? (Fact) Mediocre: FY25 ROE 8.4%, ROIC ~10.8%, ROA 5.5% — barely at/above WACC. No segment earns >13% operating margin.

How profitable is the industry — competitors, barriers to entry? (Interpretation) High barriers (flight-critical qualification, decades-long design-win lock-in, ITAR), but a moderate profit pool because oligopsony buyers (Boeing, Airbus, Lockheed, U.S. Government) capture much of the surplus. Peers that own proprietary aftermarket (TransDigm ~50% EBITDA margin, HEICO 20%+ ROE) earn far more than component/OEM suppliers like Moog.

Can the business be easily understood? Yes at the franchise level (mission-critical actuation with switching costs); no at the fine-grained program level (classified defense work, complex long-cycle contract accounting — see the aftermarket rev-rec restatement).

Can it be undermined by foreign low-cost labor? (Interpretation) Largely no — flight-critical/ITAR qualification and man-rated certification protect against commoditization; but the Industrial segment is more exposed, and tariffs are a live cost headwind.

Do brands matter? Nature of competition? Switching costs? Brand per se is minor; what matters is qualification lock-in and engineering reputation (100% on-time/quality delivery wins share when primes are capacity-constrained). Switching costs are high and real — requalifying an alternative mid-program is a multi-year undertaking. Competition is on design wins and program capture, not price on installed content.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? (Interpretation) The design-win/qualification moat and long-lived program positions are intangible economic assets not on the balance sheet. Conversely, tangible book is thin (~$34/share; goodwill $842M + intangibles $66M).

Off-balance-sheet liabilities? Pension is on-balance-sheet, underfunded a modest ~$157M (declining). Operating leases and long-term purchase commitments are routine. No unusual off-balance-sheet exposure identified.

How conservative is the accounting? (Interpretation) Mixed. Positives: low SBC (~0.4% of sales), no non-operating income flatter, reasonable ~25% tax rate, GAAP≈adjusted EPS. Caution: a FY25 commercial-aftermarket revenue-recognition restatement (Notes 1 & 25) in the highest-growth segment, and serial “one-time” restructuring/impairment/simplification charges that inflate the GAAP-to-adjusted margin wedge (GAAP op margin 10.6% vs adjusted 13.0%).

How CapEx-hungry is the business? (Fact) Moderately high — capex 3.7–5.3% of sales (~1.4x depreciation) for the defense-ramp capacity build; combined with a ~118-day cash-conversion cycle, growth self-funds poorly.

Capital Allocation & Management

How much FCF, and how is it used? (Fact) FCF has been weak/volatile (FY23 −$38M; FY25 $128M = 55% of net income; TTM ~$310M, seasonally Q4-loaded). Uses: deleveraging, capex, a modest buyback ($100.7M FY25 at ~$197 avg), and a small dividend (~15.5% payout). Philosophy is conservative and balance-sheet-first.

Significant acquisitions recently? No transformative M&A — small bolt-ons (COTSWORKS, DCL) offset by Industrial divestitures. A new Chief Strategy & Corp Dev role signals future intent.

Buying back shares? Issuing to insiders? Modest opportunistic buybacks; diluted share count down ~4% over five years, partly offset by SBC. Not a serial diluter.

Compensation policy / motivations of management? (Fact — key flaw) Incentives pay on consolidated sales + adjusted operating margin — no ROIC, FCF, or relative-TSR metric. This rewards growth and margin, not returns on capital — the exact design that yields a company compounding sales/margin while ROIC languishes at WACC. Dual-class Class B family/trust control elects the board majority; no activist catalyst.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a U.S. C-corporation with dual-class common (MOG-A limited-vote / MOG-B board-controlling). Standard 1099 dividend; no K-1.

Dividend policy? Small and growing — $1.15/share FY25 (~15.5% payout), raised January 2026. Not the return driver.

How profitable is the business? (Fact) Average — ~11% operating margin, ~8% ROE, ~11% ROIC (see above).

Is net income diverging from cash from operations? (Fact) Yes, historically — FCF conversion is only ~55–60% of net income due to working-capital intensity; the two converge only in seasonally strong Q4. A genuine watch-item.

Risks & Downside

What factors would cause the stock to decline? (Interpretation) Primarily multiple de-rating from the 98th percentile (the dominant risk), triggered by: margin gains proving cyclical, a book-to-bill roll-over, a momentum-factor rotation, a defense budget/CR disruption, growing tariff drag, or any single guide-down. Fundamental risks are individually manageable but collectively erode the earnings quality a ~39x multiple requires.

Risk of a catastrophic loss? (Interpretation) Low in the near term — conservative balance sheet (net debt/EBITDA 1.72x, 7.1x interest coverage), diversified programs, real backlog. A systemic flight-critical product-liability event is low-probability/high-impact tail risk. The realistic “loss” here is a large drawdown from a rich multiple, not insolvency (lifetime max drawdown on record is −64%).

Chance of a total loss? Negligible — this is a solvent, cash-generative, mission-critical franchise. The risk is price, not survival.

Recent News & Events (dated timeline, FY25–present)

• 2025-04-25 — FQ2 FY25: adj EPS $1.92 vs $2.19 PY (down YoY) — tariff/supply-chain trough; dividend declared.
• 2025-07-07 — Acquired COTSWORKS Inc. (fiber-optic components; aero/defense bolt-on).
• 2025-07-25 — FQ3 FY25: record sales + EPS; adj EPS $2.37 vs $1.91 (+24%); back-half recovery begins.
• 2025-11-21 — FQ4/FY25: record Q4 sales, adj op margin, FCF; FY25 GAAP dil EPS $7.33 (+14%), revenue $3,861M (+7%); issued FY26 guidance (~$10.00); announced prior-period restatement (commercial-aftermarket rev-rec).
• 2025-12-11 — Niron Magnetics partnership: rare-earth-free actuators for guided munitions.
• 2025-12 / 2026-01 — Serial 52-week highs; multiple momentum-stock notes.
• 2026-01-30 — FQ1 FY26: revenue +21%, record sales all four segments, adj EPS $2.63 vs $1.78; 12-mo backlog +30%; >$1B commercial bookings, >$100M PAC-3 order, >$100M Meteor satellite order; raised FY26 guide to $10.20; increased quarterly dividend (~$0.30); created Chief Strategy & Corp Dev Officer role.
• 2026-02-12 — Presented at TD Cowen Aerospace & Defense Conference.
• 2026-03-09/10 — Announced + priced $500M 5.5% senior notes due 2034; refinanced/extended revolver + term loan; called 4.25% notes due <2yr.
• 2026-04-24 — FQ2 FY26: revenue +13%, adj EPS $2.64 vs $1.92 (+38%); record 12-mo backlog $3.31B (+33% YoY); adj op margin 13.4%; Space & Defense +16% (EBIT margin 14.6%, +200bps); raised FY26 guide to $10.60 ±$0.20; exited general-aviation avionics.
• 2026-05-19 — Echodyne + Moog demonstrate RIwP counter-UAS system at U.S. Army exercise.
• 2026-06-19 — Zacks upgrade to Buy; continued momentum (stock ~$410, +68% YTD; 5-yr high $425.85 on 2026-06-29).
• 2026-07-01 — Carl R. Christenson (ex-Altra Industrial Motion Chairman/CEO) elected Class A director; board 9→10.
• 2026-07-20 — JPMorgan initiates Overweight, $520 target.
• 2026-07-31 — FQ3 FY26 earnings scheduled (guide ~$2.65).

Has the business environment changed recently? (Interpretation) Yes, favorably on demand (defense super-cycle, commercial recovery) and unfavorably on cost (tariffs, Middle East). The news flow is overwhelmingly positive — a crowded momentum setup, not a contrarian/distressed one; the absence of any bearish catalyst is itself a positioning risk.

Change in accounting policies? The FY25 commercial-aftermarket revenue-recognition restatement (immaterial per management, but in the highest-growth segment). Otherwise routine.

APPENDIX B — Source Appendix — Moog Inc. (NYSE: MOG-A)

All sources accessed 2026-07-24 unless otherwise noted. Primary sources (SEC filings, company disclosures, earnings-call transcripts) listed first; third-party aggregated data and media thereafter. Fact / Interpretation separation is maintained throughout; this appendix records provenance.

1. Primary — SEC Filings (via SEC EDGAR)

2. Primary — Earnings-Call Transcripts (via ROIC.ai)

3. Primary — Company Disclosures & Press (BusinessWire)

• Q1/Q2 FY2026 earnings releases and guidance raises (2026-01-30, 2026-04-24).
• $500M 5.50% senior notes offering & pricing (2026-03-09/10).
• Carl R. Christenson elected Class A director; board 9→10 (2026-07-06).
• COTSWORKS Inc. acquisition (2025-07-07).
• Niron Magnetics partnership — rare-earth-free actuators (2025-12-11).
• Echodyne + Moog RIwP counter-UAS demonstration (2026-05-19).
• Cash-dividend declarations / increase (2026-01-30, 2026-04-24).
• FQ3 FY2026 earnings date announcement (2026-07-15).

4. Third-Party — Quantitative Data (reconciled to filings)

• ROIC.ai MCP — income statement, balance sheet, cash flow, profitability ratios (ROE/ROA/ROIC/margins), enterprise value, valuation multiples, per-share data; for MOG-A and peers CW/WWD/HEI/TDG/ITT/PH. Third-party aggregated; reconciled to the 10-K (e.g., corrected the “non-operating income” and “$643M FCFF” misreads against the actual charge table and cash-flow statement).
• AZI (azitrading.com) — five-year daily OHLC price series (adjusted/unadjusted, EMAs, beta/alpha) and the valuation-index own-history percentile ranks (composite 97.9th; P/E 94.4th, P/B 99.6th, P/S 99.6th).
• FactorsToday (factorstoday.com/api) — stock loadings (Market/SmallSize/DividendYield/Aero&Defense/Momentum), leaderboard (Sharpe/return/drawdown by horizon), stock-info (beta/alpha/relative strength), specific-vol, related-stocks (factor-similar momentum ETFs). Third-party statistical estimates.

5. Third-Party — Industry & Media

• Reuters / Safran press release / militaryaerospace.com / Janes (Jul 2025) — Safran’s $1.8B acquisition of Collins Aerospace flight-control/actuation business; DOJ-remedy divestiture of Collins EMA to Woodward; ~25% Safran share of the ~$11.2B flight-control market.
• JPMorgan — initiation of Overweight, $520 price target (2026-07-20; via CNBC/Moomoo).
• TD Cowen — price target raised to $450 (2026-06-10; via TipRanks); Truist upgrade to Strong-Buy (2025-05-01).
• MarketBeat — consensus average price target ~$485; consensus “Buy”.
• Zacks / Seeking Alpha — quarterly EPS-surprise history; momentum/52-week-high coverage; buy-rated thesis pieces (used as sentiment/consensus indicators, not as evidence).
• moog.com — market/program pages (missiles, space, flight controls) for platform/program corroboration.

6. Analytical Frameworks

• Greenwald (Competition Demystified): moat taxonomy (intangibles + customer captivity), share-stability and ROIC tests; Marathon (Capital Returns): supply-side capital-cycle analysis applied to consolidating A&D actuation vs. pruned Industrial.